The Ottawa Hospital, IBD Centre of Excellence
Welcome,         Profile    Billing    Logout  
 2 Trials 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Murthy, Sanjay
IBDDysplasia, NCT04067778: IBD Neoplasia Surveillance Pilot RCT

Completed
N/A
600
Canada
Intervention Group, Control Group
Ottawa Hospital Research Institute, Health Sciences Centre, Winnipeg, Manitoba, Western University, Canada, University of Toronto, Hamilton Health Sciences Corporation, Thunder Bay Regional Health Sciences Centre, Eastern Health, McGill University Health Centre/Research Institute of the McGill University Health Centre, Providence Health & Services, Royal Jubilee Hospital, University of Alberta, MOUNT SINAI HOSPITAL, Nova Scotia Health Authority
Inflammatory Bowel Diseases, Colonic Neoplasms, Dysplasia
09/22
10/22
NCT03261102: TDM Guided Early Optimization of ADAL in Crohn's Disease

Recruiting
N/A
200
Canada
Adalimumab, Humira
waqqas.afif, AbbVie
Crohn Disease, Drug Monitoring, Inflammatory Bowel Diseases
12/23
06/24
NCT05809999: IBD Neoplasia Surveillance RCT

Recruiting
N/A
1952
Canada
Standard colonoscopy with targeted biopsies
Ottawa Hospital Research Institute
Colonic Neoplasms, Inflammatory Bowel Diseases, Dysplasia
12/25
02/26
Tessier, Melissa
TRACTION, NCT04803747: A Trial of a Hospital Policy of Tranexamic Acid Use to Reduce Transfusion in Major Non-cardiac Surgery

Active, not recruiting
4
8440
Canada
Tranexamic acid (TXA), Placebo (0.9 % Saline)
University of Manitoba, Canadian Institutes of Health Research (CIHR), Health Sciences Centre Foundation, Manitoba, The Ottawa Hospital
Major Non-cardiac Surgeries
03/24
10/24
NCT03261102: TDM Guided Early Optimization of ADAL in Crohn's Disease

Recruiting
N/A
200
Canada
Adalimumab, Humira
waqqas.afif, AbbVie
Crohn Disease, Drug Monitoring, Inflammatory Bowel Diseases
12/23
06/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Murthy, Sanjay
IBDDysplasia, NCT04067778: IBD Neoplasia Surveillance Pilot RCT

Completed
N/A
600
Canada
Intervention Group, Control Group
Ottawa Hospital Research Institute, Health Sciences Centre, Winnipeg, Manitoba, Western University, Canada, University of Toronto, Hamilton Health Sciences Corporation, Thunder Bay Regional Health Sciences Centre, Eastern Health, McGill University Health Centre/Research Institute of the McGill University Health Centre, Providence Health & Services, Royal Jubilee Hospital, University of Alberta, MOUNT SINAI HOSPITAL, Nova Scotia Health Authority
Inflammatory Bowel Diseases, Colonic Neoplasms, Dysplasia
09/22
10/22
NCT03261102: TDM Guided Early Optimization of ADAL in Crohn's Disease

Recruiting
N/A
200
Canada
Adalimumab, Humira
waqqas.afif, AbbVie
Crohn Disease, Drug Monitoring, Inflammatory Bowel Diseases
12/23
06/24
NCT05809999: IBD Neoplasia Surveillance RCT

Recruiting
N/A
1952
Canada
Standard colonoscopy with targeted biopsies
Ottawa Hospital Research Institute
Colonic Neoplasms, Inflammatory Bowel Diseases, Dysplasia
12/25
02/26
Tessier, Melissa
TRACTION, NCT04803747: A Trial of a Hospital Policy of Tranexamic Acid Use to Reduce Transfusion in Major Non-cardiac Surgery

Active, not recruiting
4
8440
Canada
Tranexamic acid (TXA), Placebo (0.9 % Saline)
University of Manitoba, Canadian Institutes of Health Research (CIHR), Health Sciences Centre Foundation, Manitoba, The Ottawa Hospital
Major Non-cardiac Surgeries
03/24
10/24
NCT03261102: TDM Guided Early Optimization of ADAL in Crohn's Disease

Recruiting
N/A
200
Canada
Adalimumab, Humira
waqqas.afif, AbbVie
Crohn Disease, Drug Monitoring, Inflammatory Bowel Diseases
12/23
06/24

Download Options